RECURRENT GLIOBLASTOMA MULTIFORME

Clinical trials for RECURRENT GLIOBLASTOMA MULTIFORME explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GLIOBLASTOMA MULTIFORME trials appear

Sign up with your email to follow new studies for RECURRENT GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

First patients test new brain cancer drug in race against time

Disease control Recruiting now

This is the first study to give the experimental drug AZD1390 to people. It aims to find a safe dose of AZD1390 to give alongside standard radiation therapy for patients with aggressive brain tumors, including glioblastoma and cancer that has spread to the brain. The main goal is…

Matched conditions: RECURRENT GLIOBLASTOMA MULTIFORME

Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

RECURRENT GLIOBLASTOMA MULTIFORME

Get alerted when new RECURRENT GLIOBLASTOMA MULTIFORME trials appear

First patients test new brain cancer drug in race against time